Analyst Coverage Initiated: YMAB rating Outperform by BMO Capital Markets
Price Target: $27
Report Date: 06-24-2022
Symbol: YMAB - Y-mAbs Therapeutics
Sector:
Industry:
Analyst Coverage Initiated: YMAB rating Outperform by BMO Capital Markets
Price Target: $27
,